Happy Holidays—Our $30 Gift Card just for you, and books ship free! Shop now>>

Hormone Therapy and Castration Resistance of Prostate Cancer

Editors: Arai, Yoichi, Ogawa, Osamu (Eds.)

Free Preview
  • Elucidates the current status of hormone therapy for prostate cancer
  • Clarifies the differences between the evidence from Japan and that from Western countries on hormone therapy for prostate cancer
  • Broadens the reader’s understanding of castration-resistant prostate cancer
see more benefits

Buy this book

eBook $139.00
price for USA in USD (gross)
  • ISBN 978-981-10-7013-6
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $179.00
price for USA in USD
  • ISBN 978-981-10-7012-9
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $179.00
price for USA in USD
  • ISBN 978-981-13-3906-6
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
About this book

This comprehensive reference expounds the current state of hormone therapy and castration resistance of prostate cancer (PCa). Previously, the incidence of PCa in Asian countries was relatively low, but it has been increasing dramatically in recent years. Although most of the new cases are diagnosed in early stages, a significant proportion of patients receive hormone therapy for metastatic disease or for relapse after local treatment. Thus the situation has gradually changed toward earlier and longer use of hormone therapy. The malignancy finally forms castration-resistant prostate cancer (CRPC) despite the lack of testicular androgen. With advances in understanding of the molecular basis of hormone dependence and CRPC, many new androgen receptor-targeted agents have emerged.

During the last decade, much evidence on hormone therapy has been accumulated in Japan. Interestingly, some of these findings are different from those reported from Western countries, suggesting ethnic variation in the outcome of hormone therapy. In the chapters of this book, expert authors provide exhaustive interpretations of the evidence recently reported from Japan and provide important Asian perspectives on hormone therapy for PCa. This work benefits not only Asian urologists but also their Western counterparts and all physicians and medical personnel who are involved in the treatment of PCa.

About the authors

Dr. Yoichi Arai,

Professor and Chairman,

Department of Urology,

Tohoku University School of Medicine

 

Dr. Osamu Ogawa,

Professor and Chairman,

Department of Urology,

Kyoto University Graduate School of Medicine

Reviews

“This is a comprehensive review of the use of androgen deprivation as treatment for men with prostate cancer. … This is a high quality review of the use of ADT in prostate cancer treatment and is a useful resource for any physician or practitioner interested in understanding the use of ADT in men with prostate cancer.” (James R. Mark, Doody's Book Reviews, December 7, 2018)

Table of contents (43 chapters)

Table of contents (43 chapters)
  • Introduction

    Pages 1-2

    Arai, Yoichi (et al.)

  • Recent Trends in Hormone Therapy for Prostate Cancer in Japan

    Pages 3-11

    Onozawa, Mizuki (et al.)

  • Risk Assessment Among Patients Receiving Primary ADT for Prostate Cancer

    Pages 13-18

    Hinotsu, Shiro, M.D.

  • Patient-Derived Xenografts for Research on Hormonal Therapy of Prostate Cancer

    Pages 19-30

    Inoue, Takahiro, M.D., Ph.D.

  • Impact of GnRH Antagonist and LHRH Agonist on the Gonadal Axis

    Pages 31-40

    Miyazawa, Yoshiyuki (et al.)

Buy this book

eBook $139.00
price for USA in USD (gross)
  • ISBN 978-981-10-7013-6
  • Digitally watermarked, DRM-free
  • Included format: EPUB, PDF
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $179.00
price for USA in USD
  • ISBN 978-981-10-7012-9
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Softcover $179.00
price for USA in USD
  • ISBN 978-981-13-3906-6
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Hormone Therapy and Castration Resistance of Prostate Cancer
Editors
  • Yoichi Arai
  • Osamu Ogawa
Copyright
2018
Publisher
Springer Singapore
Copyright Holder
Springer Nature Singapore Pte Ltd.
eBook ISBN
978-981-10-7013-6
DOI
10.1007/978-981-10-7013-6
Hardcover ISBN
978-981-10-7012-9
Softcover ISBN
978-981-13-3906-6
Edition Number
1
Number of Pages
VIII, 433
Number of Illustrations
31 b/w illustrations, 34 illustrations in colour
Topics